Valeant Pharmaceuticals (VRX) in Focus: Stock Jumps 6.2% – Tale of the Tape

Zacks

Valeant Pharmaceuticals International, Inc. (VRX) was a big mover last session, as the company saw its shares rise over 6% on the day. The price increased after the company posted better-than-expected guidance for 2015. As a result, volume was solid, with far more shares changing hands than in a normal session. This continues the recent uptrend for the company as the stock is now up 9.81% since Dec 24, 2014.

None of the estimates for this stock were revised over the past 30 days. The Zacks Consensus Estimate also remained unchanged over the same time frame. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Valeant currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the same industry is Shire plc (SHPG), carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

To read this article on Zacks.com click here.

Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.

Be the first to comment

Leave a Reply